Effect of Orally Administered Phenylalanine with and without Glucose on Insulin, Glucagon and Glucose Concentrations

 

 Buy Article Permissions and Reprints

Abstract

Objective: As part of our studies of the metabolic effects of ingested proteins, we are currently investigating the effects of ingestion of individual amino acids. The objective of the present study was to determine whether ingested phenylalanine stimulates insulin and/or glucagon secretion, and if phenylalanine ingested with glucose modifies the insulin, glucagon or glucose response to the ingested glucose. Design: Six healthy subjects were tested on 4 separate occasions. Plasma phenylalanine, glucose, insulin, glucagon, and total alpha amino nitrogen (AAN) (i.e., total amino acids) concentrations were measured at various times during a 2.5 h period after ingestion of 1 mmol phenylalanine/kg lean body mass, 25 g glucose, 1 mmol phenylalanine/kg lean body mass+25 g glucose, or water only, given in random order. Results: Following phenylalanine ingestion, the circulating phenylalanine concentration increased ∼ 14 fold and remained elevated for the duration of the experiment. Glucagon and AAN increased, insulin increased modestly, and glucose was unchanged when compared to water ingestion. When glucose was ingested with phenylalanine, the circulating phenylalanine, glucagon, AAN, and insulin area responses were approximately the sum of the responses to phenylalanine alone and glucose alone. However, the plasma glucose area response was decreased 66% when phenylalanine was co-ingested with glucose. Conclusion: In summary, phenylalanine in an amount moderately greater than that in a large protein meal stimulates an increase in insulin and glucagon concentration. It markedly attenuates the glucose-induced rise in plasma glucose when ingested with glucose.

References

• 1 Fajans SS, Floyd JCJ, Knopf RF, Conn JW. Effect of amino acids and proteins on insulin secretion in man.  Recent Prog Horm Res. 1967;  23 617-622
  PubMedGoogle Scholar
• 2 Nuttall FQ, Gannon MC. Metabolic response to dietary protein in persons with and without diabetes mellitus.  Diabetes Nutr Metab. 1991;  4 71-88
  PubMedGoogle Scholar
• 3 Pek S, Fajans SS, Floyd Jr. JC, Knopf RF, Conn JW. Effects upon plasma glucagon of infused and ingested amino acids and of protein meals in man.  Diabetes. 1969;  18 328 , (Abstr. 19)
  PubMedGoogle Scholar
• 4 Floyd JC, Fajans SS, Conn JW, Knopf RF, Rull J. Stimulation of insulin secretion by amino acids.  J Clin Invest. 1966;  45 1487-1502
  CrossrefPubMedGoogle Scholar
• 5 Muller WA, Aoki TT, Cahill GFJ. Effect of alanine and glycine on glucagon secretion in postabsorptive and fasting obese man.  J Clin Endocrinol Metab. 1975;  40 418-425
  PubMedGoogle Scholar
• 6 Gannon MC, Nuttall JA, Nuttall FQ. The metabolic response to ingested glycine.  Am J Clin Nutr. 2002;  76 1302-1307
  PubMedGoogle Scholar
• 7 Gerich JE, Charles MA, Grodsky GM. Regulation of pancreatic insulin and glucagon secretion.  Annu Rev Med. 1976;  27 379-388
  CrossrefPubMedGoogle Scholar
• 8 Martinsone D, Ligere R, Martinsons A. The effect of l-tryptophan load on endocrine system of pancreas in diabetes mellitus. New York: Plenum Press 1996
  Google Scholar
• 9 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.  Diabetes Care. 1998;  21 S5-S19
  PubMedGoogle Scholar
• 10 Nuttall FQ, Gannon MC. Carbohydrates and Diabetes. In: Franz MJ, Bantle JP (eds). American Diabetes Association Guide to Medical Nutrition Therapy for Diabetes Alexandria: American Diabetes Association 1999: 85-106
  Google Scholar
• 11 Gannon MC, Nuttall JA, Nuttall FQ. Oral arginine does not stimulate an increase in insulin concentration but delays glucose disposal.  Am J Clin Nutr. 2002;  76 1016-1022
  PubMedGoogle Scholar
• 12 Nuttall FQ, Gannon MC, Jordan K. The metabolic response to ingestion of proline with and without glucose.  Metabolism. 2004;  53 241-246
  CrossrefPubMedGoogle Scholar
• 13 Fennema OR. Food Chemistry. New York: Marcel Dekker Inc. 1985
  Google Scholar
• 14 Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.  J Clin Invest. 1999;  104 787-794
  CrossrefPubMedGoogle Scholar
• 15 Floyd Jr. JC, Fajans SS, Pek S, Thiffault CA, Knopf RF, Conn JW. Synergistic effect of essential amino acids and glucose upon insulin secretion in man.  Diabetes. 1970;  19 109-115
  PubMedGoogle Scholar
• 16 Cherrington AD, Stevenson RW, Steiner KE, Davis MA, Myers SR, Adkins BA, Abumrad NN, Williams PE. Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo.  Diabetes Metab Rev. 1987;  3 307-332
  PubMedGoogle Scholar
• 17 Unger RH, Orci L. Physiology and pathophysiology of glucagon.  Physiol Rev. 1976;  56 778-826
  PubMedGoogle Scholar
• 18 Gannon MC, Nuttall JA, Damberg G, Gupta V, Nuttall FQ. Effect of protein ingestion on the glucose appearance rate in people with type 2 diabetes.  J Clin Endocrinol Metab. 2001;  86 1040-1047
  CrossrefPubMedGoogle Scholar
• 19 Saeed A, Jones S, Nuttall FQ, Gannon MC. A fasting-induced decrease in plasma glucose concentration does not affect the insulin response to ingested protein in people with type 2 diabetes.  Metabolism. 2002;  51 1027-1033
  CrossrefPubMedGoogle Scholar
• 20 Gannon MC, Nuttall FQ, Saeed A, Jordan K, Hoover H. An increase in dietary protein improves the blood glucose response in persons with type 2 diabetes.  Am J Clin Nutr. 2003;  78 734-741
  PubMedGoogle Scholar

Correspondence

Frank Q. NuttallM.D., Ph.D. 

Chief·Endocrinology, Metabolism & Nutrition·Professor of Medicine·VA Medical Center

One Veterans Drive Minneapolis·MN 55417·USA

Phone: +1/612/467 44 24

Fax: +1/612/725 22 73

Email: Nutta001@umn.edu